KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Short-Term Debt issuances: 2011-2020

Historic Short-Term Debt issuances for TherapeuticsMD (TXMD) over the last 2 years, with Mar 2020 value amounting to $50.0 million.

  • TherapeuticsMD's Short-Term Debt issuances was N/A to $50.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $52.3 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2020, which is 75.00% down from last year.
  • Latest data reveals that TherapeuticsMD reported Short-Term Debt issuances of $50.0 million as of Q1 2020, which was up 49,900.00% from $100,000 recorded in Q2 2013.
  • In the past 5 years, TherapeuticsMD's Short-Term Debt issuances ranged from a high of $50.0 million in Q1 2020 and a low of $50.0 million during Q1 2020.
  • Its 1-year average for Short-Term Debt issuances is $50.0 million, with a median of $50.0 million in 2020.